For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $12.97 in the prior trading day, Dynavax Technologies Corp (NASDAQ: DVAX) closed at $12.71, down -2.00%. In other words, the price has decreased by -$2.00 from its previous closing price. On the day, 1.82 million shares were traded. DVAX stock price reached its highest trading level at $12.97 during the session, while it also had its lowest trading level at $12.63.
Ratios:
Our goal is to gain a better understanding of DVAX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.21 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.21. For the most recent quarter (mrq), Quick Ratio is recorded 9.91 and its Current Ratio is at 10.80. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.42.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 11, 2025, Downgraded its rating to Sell and sets its target price to $12 from $15 previously.
On February 01, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $20.
On September 27, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $22.JMP Securities initiated its Mkt Outperform rating on September 27, 2022, with a $22 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 24 ’25 when Novack David F sold 10,000 shares for $14.00 per share. The transaction valued at 140,000 led to the insider holds 8,078 shares of the business.
DAVID NOVACK bought 10,000 shares of DVAX for $140,000 on Mar 24 ’25. On Mar 18 ’25, another insider, Novack David F, who serves as the President & COO of the company, sold 14,020 shares for $13.58 each. As a result, the insider received 190,392 and left with 8,078 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DVAX now has a Market Capitalization of 1576942464 and an Enterprise Value of 1117523200. As of this moment, Dynavax’s Price-to-Earnings (P/E) ratio for their current fiscal year is 72.75, and their Forward P/E ratio for the next fiscal year is 22.78. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.69 while its Price-to-Book (P/B) ratio in mrq is 2.67. Its current Enterprise Value per Revenue stands at 4.031 whereas that against EBITDA is 202.487.
Stock Price History:
The Beta on a monthly basis for DVAX is 1.26, which has changed by 0.04265797 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, DVAX has reached a high of $14.63, while it has fallen to a 52-week low of $9.74. The 50-Day Moving Average of the stock is -4.82%, while the 200-Day Moving Average is calculated to be 5.42%.
Shares Statistics:
The stock has traded on average 2.19M shares per day over the past 3-months and 1934010 shares per day over the last 10 days, according to various share statistics. A total of 125.45M shares are outstanding, with a floating share count of 118.29M. Insiders hold about 4.66% of the company’s shares, while institutions hold 101.92% stake in the company. Shares short for DVAX as of 1741910400 were 18946024 with a Short Ratio of 8.64, compared to 1739491200 on 20044350. Therefore, it implies a Short% of Shares Outstanding of 18946024 and a Short% of Float of 18.89.
